Trustees of Columbia University in the City of New York’s Seres Therapeutics MCRB Stock Holding History

Trustees of Columbia University in the City of New York’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,997	Closed	-$1.47M	–	19
2020 Q4	$1.47M	Buy	+2,997	New	+$1.76M	1.96%	4

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trustees of Columbia University in the City of New York's MCRB Position: Q1 2021 in Review

Trustees of Columbia University in the City of New York sold out of Seres Therapeutics (MCRB) in Q1 2021, closing a stake of 2,997 shares — an estimated $1.47M sold.

Trustees of Columbia University in the City of New York first reported a position in MCRB in Q4 2020 and held it in 1 quarter. The position peaked at $1.47M in Q4 2020. 152 funds tracked by Wall St. Rank hold MCRB as of Q1 2021.

Trustees of Columbia University in the City of New York reported no remaining Seres Therapeutics position as of Q1 2021 after selling out during the quarter.
Trustees of Columbia University in the City of New York sold 2,997 Seres Therapeutics shares in Q1 2021, an estimated $1.47M.
Trustees of Columbia University in the City of New York first reported a position in Seres Therapeutics in Q4 2020 and held it in 1 quarter.
Trustees of Columbia University in the City of New York's Seres Therapeutics position peaked at $1.47M in Q4 2020.
152 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2021.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q1 2021, filed 17 May 2021.